Insulin Makers Ask Justices To Review Collusion Case
By Matthew Perlman · March 11, 2026, 6:44 PM EDT
Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP have told the U.S. Supreme Court that a ruling reviving a case over insulin drug costs undermines key...
To view the full article, register now.